Mismatch repair/microsatellite instability (MMR/MSI) testing practices among United States physicians treating patients (pts) with advanced/metastatic colorectal cancer (mCRC).

被引：0
|
作者：
Eriksson, Jennifer
Amonkar, Mayur
Thomson, Gemma
Lambert, Jeremy
Malmenas, Mia
Chase, Monica
Sun, Lucy
Kollmar, Linda Grossman
Vichnin, Michelle
机构：
[1] ICON Plc, Commercialisat & Outcomes, Stockholm, Sweden
[2] Merck & Co Inc, N Wales, PA USA
[3] ICON Plc, London, England
[4] Mapi, Lyon, France
[5] ICON Plc, Stockholm, Sweden
[6] ICON Plc, Commercialisat & Outcomes, Boston, MA USA
[7] Merck & Co Inc, Kenilworth, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.533
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
533
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Clinicopathological features of microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) in Japanese patients.
    Kawazoe, Akihito
    Shitara, Kohei
    Noguchi, Masaaki
    Fukuoka, Shota
    Kuboki, Yasutoshi
    Bando, Hideaki
    Okamoto, Wataru
    Kojima, Takashi
    Doi, Toshihiko
    Ohtsu, Atsushi
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [22] RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab combination in patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI/dMMR) metastatic colorectal cancer (mCRC): Results of the GERCOR NIPICOL phase II study
    Cohen, Romain
    Bennouna, Jaafar
    Henriques, Julie
    Tournigand, Christophe
    De La Fouchardiere, Christelle
    Tougeron, David
    Borg, Christophe
    Mazard, Thibault
    Chibaudel, Benoist
    Garcia-Larnicol, Marie-Line
    Svrcek, Magali
    Vernerey, Dewi
    Menu, Yves
    Andre, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [23] Biological and therapeutic impact of tumor mutational burden in microsatellite instability/mismatch repair-deficient (MSI/dMMR) metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI)
    Deverly, Sarah Blanchet
    Raffy, Balthazar
    Ratovomanana, Toky
    Nicolle, Remy
    Nay, Paula
    Andre, Thierry
    Duval, Alex
    Cohen, Romain
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 272 - 272
  • [24] Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer who are microsatellite instability (MSI)-high or are mismatch repair deficient (dMMR) in the United States
    Kelkar, Sneha S.
    Prabhu, Vimalanand S.
    Corman, Shelby
    Odak, Shardul
    Rusibamayila, Nifasha
    Macahilig, Cynthia
    Orlowski, Robert
    Duska, Linda
    GYNECOLOGIC ONCOLOGY, 2023, 169 : 154 - 163
  • [25] Clinical outcome of patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) treated with pembrolizumab.
    Sinicrope, Frank A.
    Chakrabarti, Sakti
    Eiring, Rachel
    Mitchelll, Jessica L.
    Finnes, Heidi D.
    Hubbard, Joleen Marie
    McWilliams, Robert R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] Prognostic significance of microsatellite instability (MSI) and mismatch repair status (MMR) in African American (AA) patients with colorectal cancer (CRC) and its impact on therapy with 5Fluorouracil.
    Bari, Shahla
    Balan, Shuba
    Adamson, Paula
    Merchant, Ambreen
    Nutalapati, Snigdha
    Ajose, Taiwo
    Kagbokue, Suaka
    Jain, Sanjay R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Mismatch repair (MMR) protein expression and next-generation sequencing (NGS) result in microsatellite instability-high (MSI-H) colorectal cancer
    Park, J. H.
    Han, H. S.
    VIRCHOWS ARCHIV, 2020, 477 : S193 - S193
  • [28] Efficacy of immune checkpoint blockade in patients with advanced upper tract urothelial cancer and mismatch repair deficiency or microsatellite instability (MSI).
    Andreev-Drakhlin, Alexander
    Shah, Amishi Yogesh
    Adriazola, Ana Cecilia
    Shaw, Leah
    Lopez, Lidia
    James, Marihella
    Matin, Surena F.
    Alhalabi, Omar
    Gao Jianjun
    Siefker-Radtke, Arlene O.
    Goswami, Sangeeta
    Xiao Lianchun
    Venkatesan, Aradhana M.
    Campbell, Matthew T.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [29] Utility of Discordant Mismatch Repair-Deficiency (MMR)/Microsatellite Instability (MSI) Testing in Screening Uterine Leiomyosarcoma Patient for Lynch/Other Familial Cancer Syndromes
    Reddy, K. S.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S149 - S150
  • [30] Nivolumab ± ipilimumab in treatment (tx) of patients (pts) with metastatic colorectal cancer (mCRC) with and without high microsatellite instability (MSI-H): CheckMate-142 interim results.
    Overman, Michael J.
    Kopetz, Scott
    McDermott, Raymond S.
    Leach, Joseph
    Lonardi, Sara
    Lenz, Heinz-Josef
    Morse, Michael A.
    Desai, Jayesh
    Hill, Andrew
    Axelson, Michael D.
    Moss, Rebecca Anne
    Lin, Chen-Sheng
    Goldberg, Monica
    Andre, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345